How much does idecabtagene vicleucel (ide-cel) cost?
The provided information does not include pricing or reimbursement details for idecabtagene vicleucel (ide-cel). To answer accurately (e.g., list price per dose, average sales price, or net price after rebates), I would need a specific source such as the manufacturer’s pricing page, an insurer formulary document, CMS/Medicare data, or a published payer/provider contract.
What do people usually mean by “price” for ide-cel?
Searches for “price” typically refer to one of these:
- Wholesale acquisition cost (WAC) or list price per treatment/course
- Manufacturer’s recommended pricing
- Net price after rebates and discounts
- Medicare rates (for claims data)
- Cost-effectiveness models used in coverage decisions
If you tell me which of these you mean (or your country/market), I can narrow the answer.
Where are ide-cel prices reported (U.S. vs. other countries)?
Pricing transparency differs by region:
- In the U.S., list price/WAC and payer-specific net pricing are often reported differently, and many sources focus on separate measures (WAC vs. net).
- In other countries, prices may be set through national health technology assessment (HTA) processes or negotiated reimbursement.
If you specify the country (e.g., U.S.), I can tailor the lookup to the right type of published pricing.
Could “ide-cel price” be confused with other cell therapies?
“Price” queries sometimes get mixed up between:
- Different CAR T therapies in the same class
- Different products with similar names
- Costs tied to administration and hospital/outpatient setting vs. the product price itself
Confirming the exact product name (idecabtagene vicleucel / ide-cel) avoids pulling the wrong pricing.
Quick check: what exact output do you want?
Reply with:
1) Country/market (U.S. or which country)
2) Which “price” definition you want (WAC/list, net, Medicare, or patient out-of-pocket)
3) Whether you want per-dose or per-treatment totals
Then I can produce a focused, sourced price answer.